STERIS plc (Ireland) (STE) Stock Analysis

Q: What is the STE stock price target?

Take-profit $242.98 (+12.6% upside). Prior stop was $204.78.

Q: What are the risks of investing in STE?

Negative momentum; Below 200-day MA; Momentum score 1.4/10 — below 4.5 minimum; Death cross — 50-day MA below 200-day MA.

Q: Is STE overvalued or undervalued?

STERIS plc (Ireland) trades at a P/E of 29.7 (forward 19.2). TrendMatrix value score: 5.6/10. Overall verdict: Sell.

Q: What do analysts say about STE?

15 analysts cover STE with a consensus score of 3.9/5. Average price target: $279.

Catalyst-Driven edge

SellModerate ConfidenceUpdated 2026-04-30

Healthcare · Medical Devices

Sell if holding. Momentum 1.4/10 is below the 5.0 floor at $215.84 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Below 200-day MA.

STERIS plc is a global provider of infection prevention and sterile processing products and services for healthcare, life sciences, and pharmaceutical customers through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences.

$215.84+12.6% A.UpsideScore 5.3/10#28 of 40 Medical Devices

Stop $204.78Target $242.98(analyst − 13%)A.R:R 2.5:1

Analyst target$279.29+29.4%7 analysts

$242.98our TP

$215.84price

$279.29mean

$300

Sell if holding. Momentum 1.4/10 is below the 5.0 floor at $215.84 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Below 200-day MA. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.3/10, moderate confidence.

Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: moderate.

Thesis

Rewards

Strong earnings beat streak (3/4)

Risks

Negative momentum

Below 200-day MA

Key Metrics

P/E (TTM)29.7

P/E (Fwd)19.2

Mkt Cap$20.9B

EV/EBITDA14.3

Profit Mgn12.1%

ROE10.5%

Rev Growth9.2%

Beta1.07

Dividend1.16%

Rating analysts15

Quality Signals

Piotroski F9/9

Options Flow

P/C0.08bullish

IV49%normal

Max Pain$190-12.0% vs spot

Material Events(8-K, last 90d)

2026-04-06Item 5.02LOW
STERIS amended Transition Agreement with former CFO Michael J. Tokich, extending his part-time senior financial advisor role through March 31, 2027 at reduced salary of $60,000 per year, effective March 31, 2026. Routine compensatory amendment for former officer.
SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value5.615%0.84

Quality6.515%0.97

Growth4.615%0.69

Momentum1.410%0.14

Sentiment6.910%0.69

Insider Activity5.010%0.50

Peer Rank3.510%0.35

Technical Setup7.45%0.37

Risk Profile7.25%0.36

Catalyst6.85%0.34

Overall (Σ contributions)5.25

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd

0.0

Volume

0.0

Obv

1.0

Ma Position

1.5

Rsi

4.5

Volume distribution (falling OBV)Below 200-MA, MA slope flat

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank

3.4

Growth Rank

4.8

Quality Rank

5.8

GatesMomentum 1.4<4.5Death cross (50MA < 200MA)EARNINGS PROXIMITY 11d<=14d (soft)A.R:R 2.5 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARSuitability: Moderate

RSI

41 · Neutral

↓ 20D MA↓ 50D MA↓ 200D MADEATH CROSSSupport $210.33Resistance $227.87

Price Targets

$205

$243

A.Upside+12.6%

A.R:R2.5:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeCautious

Risk Alerts

! Momentum score 1.4/10 — below 4.5 minimum

! Death cross — 50-day MA below 200-day MA

Earnings

3/4 beats

Next Earnings2026-05-11 (11d)

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is STE stock a buy right now?

Sell if holding. Momentum 1.4/10 is below the 5.0 floor at $215.84 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Below 200-day MA. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $204.78. Score 5.3/10, moderate confidence.

What is the STE stock price target?

Take-profit target: $242.98 (+12.6% upside). Prior stop was $204.78. Stop-loss: $204.78.

What are the risks of investing in STE?

Negative momentum; Below 200-day MA.

Is STE overvalued or undervalued?

STERIS plc (Ireland) trades at a P/E of 29.7 (forward 19.2). TrendMatrix value score: 5.6/10. Verdict: Sell.

What do analysts say about STE?

15 analysts cover STE with a consensus score of 3.9/5. Average price target: $279.

What does STERIS plc (Ireland) do?STERIS plc is a global provider of infection prevention and sterile processing products and services for healthcare,...